Wellner VP, Sekura R, Meister A, Larsson A
(2014) 220:R5765
Rahman, I., et al., Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1
Injection Sites, Storage, and Handling Common handling practices include: Using 2931 g insulin syringes for subcutaneous shots Cleaning the skin with alcohol before injection Storing lyophilized powder at 28 C Refrigerating reconstituted BPC 157 and using it within 14 days Disposing of needles and vials according to biohazard guidelines Medical supervision is recommended, especially for injectable use, long protocols, peptide stacks, or athletes with existing medical conditions
Self-assembly will not occur at low concentrations (such as 8 mM)
Stuart-Focused Care: Familiar with the unique needs of Stuart residents and visitors